M&A Deal Summary |
|
|---|---|
| Date | 2020-01-01 |
| Target | Caranx Medical |
| Sector | Medical Products |
| Buyer(s) | Truffle Capital |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 700M EUR |
| Size | Middle-Market |
| Type | Sector Focused |
Truffle Capital is a French private equity firm focused on majority investments in life science and information technology companies. Within IT, Truffle seeks businesses dealing in mobile content and connectivity, internet, technical software, IT security, and VOIP. Within the life science sector, the Firm looks at opportunities in therapeutic drugs and vaccines, medical devices, as well as other breakthrough technologies. Truffle Capital was formed in 2001 and is based in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 45 of 45 |
| Sector: Medical Products M&A | 7 of 7 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 18 of 18 |
| Country: France M&A | 33 of 33 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-12-23 |
SmartPush
Marseille, France SmartPush analyzes banking data and enriches account statements using artificial intelligence to categorize transactional data. SmartPush was founded in 2016 and is based in Marseille, France. |
Buy | - |